Notify me when Robert E. Brown Jr. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 4.8% | $95,056,292 | -$13,782,000 | 1,034,570 | -13% | Robert E. Brown, Jr. | 21 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|